Table 3.

The outcome of this study (n = 83).

	Baseline	4w	8w	12w
Migraine days/4w
Ave	8.16 ± 4.53	7.63 ± 5.01	7.35 ± 4.93	6.84 ± 4.41
P-value		0.118	0.0403	0.0036
Migraine attacks/4w
Ave	5.33 ± 3.95	5.04 ± 4.32	4.33 ± 3.19	3.94 ± 2.44
P-value		0.256	0.0017	0.0002
Headache days/4w
Ave	11.48 ± 5.70	11.41 ± 6.27	10.4 ± 5.83	9.81 ± 5.66
P-value		0.874	0.0201	0.0009
Acute anti-migraine drug intake/4w
Ave	8.75 ± 4.41	8.47 ± 4.91	8.52 ± 5.22	7.83 ± 4.91
P-value		0.487	0.569	0.0166
Severity of headache (NRS)
Ave	4.5 ± 1.55	4.08 ± 1.46	4.14 ± 1.61	4.11 ± 1.66
P-value		0.058	0.099	0.122